Hypoxia initiates transcription of a number of gene products that help to sustain the supply of O 2 to tissues and to enhance cell survival during severe O 2 deprivation. Gene products that augment O 2 supply at the tissue level include erythropoietin (Epo) 1 which increases the proliferation of erythrocytes, tyrosine hydroxylase which is necessary for the synthesis of the neurotransmitter dopamine in the carotid bodies, and the angiogenic factor VEGF which stimulates growth of new capillaries (1-3). At the cellular level, gene products that enhance survival during hypoxia include the glycolytic enzymes and the glucose transporters Glut1 and Glut3 (4). The induction of these genes is mediated by hypoxia-inducible factor-1 (HIF-1) (5-7), a heterodimeric transcription factor consisting of HIF-1␣ and the aryl hydrocarbon nuclear translocator (ARNT or HIF-1␤) subunits (7-9). The significance of HIF-1 in transcriptional regulation was recently demonstrated by the marked decrease in mRNA expression of VEGF and glycolytic enzymes seen during hypoxia in HIF-1␣-or ARNT-deficient murine embryonic stem cells (10 -12).
cells. Isolated mitochondria increase ROS generation during hypoxia, as does the bacterium Paracoccus denitrificans. These findings reveal that mitochondria-derived ROS are both required and sufficient to initiate HIF-1␣ stabilization during hypoxia.
Hypoxia initiates transcription of a number of gene products that help to sustain the supply of O 2 to tissues and to enhance cell survival during severe O 2 deprivation. Gene products that augment O 2 supply at the tissue level include erythropoietin (Epo) 1 which increases the proliferation of erythrocytes, tyrosine hydroxylase which is necessary for the synthesis of the neurotransmitter dopamine in the carotid bodies, and the angiogenic factor VEGF which stimulates growth of new capillaries (1) (2) (3) . At the cellular level, gene products that enhance survival during hypoxia include the glycolytic enzymes and the glucose transporters Glut1 and Glut3 (4) . The induction of these genes is mediated by hypoxia-inducible factor-1 (HIF-1) (5-7), a heterodimeric transcription factor consisting of HIF-1␣ and the aryl hydrocarbon nuclear translocator (ARNT or HIF-1␤) subunits (7) (8) (9) . The significance of HIF-1 in transcriptional regulation was recently demonstrated by the marked decrease in mRNA expression of VEGF and glycolytic enzymes seen during hypoxia in HIF-1␣-or ARNT-deficient murine embryonic stem cells (10 -12) .
The mechanism by which HIF-1 activation is initiated during hypoxia remains unclear. Both HIF-1␣ and ARNT mRNAs are constitutively expressed, indicating that functional activity of the HIF-1␣⅐ARNT complex is regulated by post-transcriptional events. ARNT levels are not significantly affected by [O 2 ], whereas HIF-1␣ protein is rapidly degraded under normoxic conditions by the ubiquitin-proteasome system (13, 14) . Hypoxia enhances HIF-1␣ protein levels by inhibiting its degradation, thereby allowing it to accumulate, to dimerize with ARNT, and to bind to the hypoxia-responsive element (HRE) in the promoter or enhancer regions of various genes. Thus, the functional HIF-1␣⅐ARNT complex is primarily regulated by the abundance of the HIF-1␣ subunit.
Although much has been learned about the role of HIF-1 in controlling the expression of hypoxia-responsive genes, the underlying mechanism by which cells detect the decrease in [O 2 ] and initiate the stabilization of HIF-1␣ is not known. Presently, four diverse O 2 -sensing mechanisms have been proposed to mediate the transcriptional response to hypoxia (15) . Two of these models postulate the involvement of an iron-containing unit in the form of either a heme group or an iron/sulfur cluster, which undergoes a change in activity during hypoxia that triggers the transcriptional response. These models are supported by the observation that cobaltous ions, or alternatively the iron chelator desferrioxamine (DFO), stabilize HIF-1␣ under normoxic conditions (16) . However, no specific proteins with this role have been identified in mammalian systems. Two other models involve the generation of reactive oxygen species (ROS) by a flavoprotein-containing NAD(P)H oxidase or by mitochondria. The NAD(P)H oxidase theory postulates that a decrease in ROS production triggers the transcriptional response to hypoxia (17, 18) . In support of that model, exogenous H 2 O 2 was found to inhibit subsequent hypoxic stabilization of HIF-1␣ (19) . However, diphenylene iodonium (DPI), a specific flavoprotein inhibitor that blocks ROS generation by NAD(P)H oxidase, abolishes the hypoxic induction of HIF-1-dependent genes (20) , whereas the model would predict that DPI should activate the response during normoxia. We previously proposed that hypoxia partially inhibits mitochondrial electron transport, producing redox changes in the electron carriers that increase the generation of ROS. These oxidants then enter the cytosol and function as second messengers in the signaling pathway leading to stabilization of HIF-1␣ (21) . In support of this model, hypoxia failed to increase ROS production or the expression of EPO, VEGF, and glycolytic enzymes in 0 cells, which lack mitochondrial DNA and electron transport activity. Also, the response to hypoxia was abolished by the DPI, which abrogates mitochondrial ROS generation by inhibiting electron transport at the flavin site in mitochondrial Complex I (22) .
Our previous study tested whether ROS are required for the DNA binding of HIF-1 and the subsequent mRNA expression of Epo, VEGF, and glycolytic enzymes during hypoxia. However, protein levels of HIF-1␣ were not measured, so that study did not reveal whether mitochondrial ROS were required to trigger stabilization of HIF-1␣ during hypoxia. Moreover, although ROS were found to be necessary for the transcriptional response to hypoxia, it was not clear whether ROS by themselves were sufficient to initiate HIF-1␣ stabilization. Accordingly, the present study tested the following: (a) whether mitochondrial ROS are required for HIF-1␣ stabilization during hypoxia, cobalt treatment, or DFO; (b) whether cytosolic ROS are sufficient to trigger HIF-1␣ stabilization; and (c) whether mitochondrial cytochrome c oxidase serves as the O 2 sensor responsible for the redox changes underlying the increase in ROS generation during hypoxia.
EXPERIMENTAL PROCEDURES
Cell Culture-Human hepatoma 3B (Hep3B) cells and the human kidney 293 cells were cultured in ␣-minimum essential medium and Dulbecco's modified essential medium, respectively, to subconfluent conditions. Rat hepatocytes were isolated as described previously (23) and maintained in Dulbecco's modified essential medium. Media were supplemented with penicillin (100 units/ml), streptomycin (100 g/ml), and 10% heat-inactivated fetal calf serum. The 0 -293 and 0 -Hep3B cells were generated by incubating wild-type cells in medium containing ethidium bromide (25 ng/ml), sodium pyruvate (1 mM), and uridine (50 g/ml) (24) . Hypoxic conditions were achieved as described previously (21) .
Measurement of ROS-Intracellular ROS generation was assessed using 2Ј,7Ј-dichlorofluorescein diacetate (Molecular Probes). ROS in the cells cause oxidation of DCFH, yielding the fluorescent product 2Ј,7Ј-dichlorofluorescein (DCF). Cells were plated on Petri dishes and incubated with DCFH-DA (10 M) under various conditions. The media were then removed;, cells were lysed and centrifuged to remove debris, and the fluorescence in the supernatant was measured using a spectrofluorometer (excitation, 500 nm; emission, 530 nm). Data were normalized to values obtained from normoxic, untreated controls.
Preparation of Nuclear Extracts-Nuclear extracts were prepared by lysing cells in a hypotonic solution (KCl (10 mM), HEPES (10 mM), protease mixture inhibitors (Roche Molecular Biochemicals), phenylmethylsulfonyl fluoride (1 mM), freshly added, pH 7.8) for 30 min. The disrupted cells were then centrifuged at 14,000 rpm, and the pellet was resuspended in a solution containing KCl (400 mM), HEPES (20 mM), glycerol (25%, v/v), EDTA (0.2 mM), and MgCl 2 (1.5 mM) at pH 7.8 in order to lyse the nuclear membrane. The suspension was then centrifuged, and the proteins in the supernatant were quantified by Bradford reagent (Sigma).
Immunoblotting-Nuclear protein extract (30 g) was mixed with equal volume of electrophoresis buffer (1.0 ml of glycerol, 0.5 ml of ␤-mercaptoethanol, 3.0 ml of 10% SDS, 1.25 ml of Tris-HCl (1.0 M), pH 6.7, and 1-2 mg of bromphenol blue). After heating, the protein was resolved on an SDS-7.5% polyacrylamide gel and transferred to hybond ECL nitrocellulose paper (Amersham Pharmacia Biotech). After transfer, the gel was stained with Ponceau stain to verify uniform loading and transfer. Membranes were blocked with 5% milk in TBS-T (TrisHCl (10 mM), NaCl (150 mM), Tween 20 (0.1%), pH 8.0) overnight and subsequently incubated with the HIF-1␣ antibody (Novus Biological Sciences) for 3 h at room temperature. The membrane was washed with TBS-T three times and incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibody. Subsequently, the membrane was washed three times with TBS-T and analyzed by enhanced chemiluminescence (Amersham Pharmacia Biotech).
Transfection and Reporter Gene Assays-Transfections of 293 and 0 -293 cells were carried out on cells plated on 35-mm Petri dishes at 60 -80% confluence using TransIT-LT1 (Panvera) according to the manufacturer's protocol. A typical transfection was performed by using 0.5 g of the luciferase reporter driven by a trimer of murine Epo 3Ј enhancer and the Glut-1 promoter (pEpo3ЈGlut1-Luc) and 0.5 g of the pSV-␤-galactosidase (Promega) as a control vector for monitoring transfection efficiencies. In some experiments, 0.5 g of empty vector (pRc/ CMV2) or human catalase gene driven by SV40 enhancer-promoter (pZeoSV-CAT) was co-transfected with the luciferase and ␤-galactosidase. The DNA/LipofectAMINE mixture was incubated with plated cells for 24 h. Subsequently, the media were replaced and cells exposed to various conditions. Cell lysis was performed using the reporter gene lysis buffer (Promega). Replicate transfection experiments were performed with four independent DNA preparations. Luciferase assays were performed using Luciferase Assay System (Promega). ␤-Galactosidase assays were performed using the luminescent ␤-galactosidase genetic reporter system II (CLONTECH).
Determination of H 2 O 2 -The concentration of H 2 O 2 or t-butyl hydroperoxide was assessed in media of Hep3B cells using the xylenol orange assay (25) . Cells were incubated in serum-free ␣-medium without phenol red (Life Technologies, Inc.) with H 2 O 2 (25 or 40 M) for 30 min with samples (900 l) taken every 5 min (Fig. 4A) , or with t-butyl hydroperoxide (25 or 40 M) for 120 min with samples (900 l) taken every 30 min (Fig. 4B) . The aliquots of media were incubated at 25°C for 45 min with 100 l of a 10ϫ xylenol orange stock solution (xylenol orange (10 M), Fe(NH 4 ) 2 (SO 4 ) 2 ⅐6H 2 O (2.5 M), H 2 SO 4 (25 mM), (Sigma)) after which the absorbance was read at 590 nm (25) . The concentration of H 2 O 2 or t-butyl hydroperoxide was determined from a standard curve (0, 25, and 40 M). Fresh stock solutions of H 2 O 2 (10 mM) and t-butyl hydroperoxide were prepared immediately prior to each trial.
Isolation of Mitochondria-Rat liver mitochondria were isolated by differential centrifugation from the livers of adult rats. The liver homogenate was prepared using a Dounce homogenizer at 4°C in buffer containing mannitol (200 mM), sucrose (70 mM), HEPES (10 mM), and EGTA (1.0 mM), at pH 7.2. The homogenate was spun for 10 min at 750 ϫ g, and the supernatant was spun at 10,000 ϫ g to recover the mitochondrial fraction. Mitochondria were suspended in sucrose buffer (sucrose (250 mM), HEPES (20 mM), KCl (5 mM), KH 2 PO 4 (3 mM), MgCl 2 (1.5 mM), EGTA (1 mM), pH 7.2) at a protein concentration of 0.1 mg/ml at 25°C and were incubated with succinate (5 mM), antimycin (1 g/ml), rotenone (1 g/ml), and DCFH-DA (10 M) for 30 min in spinner flasks. Subsequently, a mitochondrial aliquot (100 l) was lysed with 1 ml of H 2 O, and the sample fluorescence was measured using a spectrofluorometer. The head space of the spinner flasks was gassed with various O 2 concentrations as described previously (26) .
Isolation and Growth of Paracoccus denitrificans-Wild-type P. denitrificans (ATCC, Rockville MD) were grown aerobically with succinate as the carbon source as described previously (49) . Bacteria were harvested in mid-logarithmic growth phase and washed twice with KH 2 PO 4 (50 mM). Cells were suspended in Krebs-Henseleit buffer (NaCl (120 mM), HEPES (20 mM), CaCl 2 (1 mM), glucose (10 mM), KCl (2.5 mM), MgSO 4 (1 mM) and KH 2 PO 4 (1 mM), pH 7.4) at 25°C. Cells were incubated for 60 min with DCFH-DA (10 M) in spinner flasks gassed with various O 2 concentrations. Subsequently, fluorescence was measured from an aliquot of media.
RESULTS

Hypoxia and Cobalt, but Not Desferrioxamine, Increase ROS
Production-Intracellular ROS generation was examined in human Hep3B cells in response to hypoxia, cobalt chloride (CoCl 2 ), or DFO using 2Ј,7Ј-dichlorofluorescein (DCFH) (27) . This probe enters the cells and can be oxidized in the presence of ROS, generating the fluorescent compound, DCF. Previous studies have indicated that DCFH oxidation can be mediated by H 2 O 2 but not by superoxide (28) . Hep3B cells incubated with DCFH for 6 h during hypoxia (1.5% O 2 ) or with CoCl 2 (100 M) during normoxia demonstrated an increase in DCF fluorescence ( Fig. 1, A and B) . By contrast, DFO (100 M) did not elicit an increase in DCF fluorescence over the same period (Fig. 1C) . The increase in DCF fluorescence induced by hypoxia or CoCl 2 was abolished by the thiol reductant pyrrolidine dithiocarbamate (PDTC, 20 M) (Fig. 1, A and B) . PDTC can enhance the scavenging of H 2 O 2 by maintaining cellular stores of reduced glutathione (GSH). ROS can be generated at a number of intracellular sites, including NAD(P)H oxidases and at mitochondrial Complex III. DPI inhibits electron transport in flavin-containing systems including NAD(P)H oxidase and mitochondrial Complex I. DPI (10 M) attenuated the increase in DCF fluorescence in response to hypoxia but not to CoCl 2 ( Fig.  1, A and B) . Mitochondrial ROS generation at Complex III can be attenuated by inhibiting electron flux at more upstream sites. Rotenone (1 g/ml), an inhibitor of electron transport at Complex I, abolished the increase in DCF fluorescence during hypoxia but not during CoCl 2 incubation (Fig. 1, A and B) . By contrast, antimycin A (1 g/ml), an inhibitor of the downstream end of Complex III, did not alter the increase in DCF fluorescence. Superoxide generated within mitochondria would require anion channels to enter the cytosol, where it would be converted to H 2 O 2 by cytosolic superoxide dismutase (29) . The inhibitor of mitochondrial anion channels 4,4Ј-diisothiocyanatostilbene-2,2Ј-disulfonate (DIDS) should therefore suppress the egress of superoxide from the mitochondria (30) . Indeed, DIDS (150 M) abolished the increase in DCF fluorescence during hypoxia (Fig. 1A) . By contrast, DIDS failed to attenuate the CoCl 2 -stimulated increase in the DCF signal (Fig. 1B) . These results support the conclusion that hypoxia stimulates mitochondrial ROS generation, that CoCl 2 stimulates ROS generation by a non-mitochondrial mechanism, and that desferrioxamine does not affect ROS production.
Stabilization of HIF-1␣ during Hypoxia Requires an Increase in Mitochondrial ROS-Hep3B cells were exposed to hypoxia, CoCl 2 , or DFO in the presence of PDTC to examine whether increases in ROS are required for the HIF-1␣ stabilization. PDTC abolished the hypoxia-and CoCl 2 -induced stabilization of HIF-1␣ but had no effect on DFO-induced stabilization of HIF-1␣ protein ( Fig. 2A) . Furthermore, human epithelial kidney 293 cells transiently co-transfected with a luciferase reporter construct driven by the HRE and a construct containing catalase (31) were exposed to hypoxia, CoCl 2 , or DFO. Catalase expression significantly attenuated the expression of luciferase in response to hypoxia or CoCl 2 , whereas the response to DFO was unaffected (Fig. 2B) . HIF-1␣ protein accumulation and HRE-luciferase expression were examined in 0 -Hep3B cells and 0 -293 cells, respectively, to determine whether mitochondria function as the source of ROS required for activation of HIF-1 during hypoxia. The 0 -Hep3B cells failed to accumulate HIF-1␣ protein during hypoxia (Fig. 2C) . By contrast, CoCl 2 and DFO still stabilized HIF-1␣ protein in 0 -Hep3B cells (Fig.  2C) . Hypoxia-induced HRE-luciferase expression was not detected in 0 -293 cells, but these cells still demonstrated HREluciferase expression in response to CoCl 2 or DFO (Fig. 2D) . The CoCl 2 -induced increase in HRE-luciferase expression in 0 -293 cells was abolished in cells co-transfected to overexpress catalase (Fig. 2D) . To clarify further the role of mitochondria in the hypoxic response, wild-type Hep3B cells were exposed to hypoxia, CoCl 2 , or DFO in the presence of rotenone (1 g/ml), DPI (10 M), DIDS (150 M), or antimycin A (1 g/ml). Rotenone, DPI, and DIDS all abolished the accumulation of HIF-1␣ during hypoxia but not during CoCl 2 or DFO treatment (Fig. 3 , A-C). Antimycin A augments ROS generation at Complex III (32, 33) , which should mimic the response to hypoxia and lead to stabilization of HIF-1␣. Yet antimycin A failed to stabilize HIF-1␣ during normoxia and did not abrogate the induction of HIF-1␣ during hypoxia, CoCl 2 , or DFO (Fig. 3D) . We had previously reported that the ROS response to antimycin A during normoxia was smaller than the response to hypoxia in Hep3B cells (21) , which suggests that ROS signaling by antimycin A may have been inadequate. We therefore tested whether stabilization of HIF-1␣ during normoxic antimycin A treatment might be amplified in cells whose ability to degrade H 2 O 2 is impaired. Hep3B cells were treated for 16 h with buthionine-L-sulfoximine (100 M) to deplete glutathione stores in an attempt to amplify the response to an oxidizing stimulus evoked by antimycin A (34). Glutathione-depleted Hep3B cells demonstrated HIF-1␣ accumulation under normoxia in the presence of antimycin A (Fig. 3E) . Rotenone, DPI, and DIDS all abolished this response, confirming the specificity of mitochondrial involvement (Fig. 3E) . These results support the hypothesis that mitochondrial ROS are required and sufficient for stabilization of HIF-1␣ during hypoxia and that non-mitochondrial ROS generation is involved in the response to CoCl 2 . DFO responses require neither the mitochondria nor ROS, suggesting that this compound acts at a more distal step in the signaling cascade.
Exogenous Peroxide Stabilizes HIF-1␣ Protein during Normoxia-The observation that catalase abolishes the hypoxiaand CoCl 2 -induced stabilization of HIF-1␣ suggests that H 2 O 2 acts as a signaling element in this response. If so, then exogenous administration of peroxide should stabilize HIF-1␣ during normoxia. Accordingly, boluses of H 2 O 2 or t-butyl hydroperoxide, a more stable analogue of H 2 O 2 , were added to culture media of normoxic Hep3B cells. Serum-free media was used because catalase in serum would otherwise rapidly degrade any added peroxide. In the absence of serum, a bolus of H 2 O 2 added to achieve an initial concentration of 25 or 40 M was progressively degraded over 30 min (Fig. 4A) . t-Butyl hydroperoxide (25 or 40 M) produced a more sustained elevation, but it, too, was largely degraded within 1 h (Fig. 4B ). To produce a more sustained elevation in H 2 O 2 levels, Hep3B cells were treated with repeated boluses of H 2 O 2 or t-butyl hydroperoxide (25 M or 40 M) every 15 min for 2 h. This regimen was sufficient to trigger the stabilization of HIF-1␣ protein levels (Fig. 4C) . Hydrogen peroxide failed to stabilize HIF-1␣ when bolus concentrations were lowered to 10 M (data not shown).
In 293 cells transfected with the HRE-luciferase expression (Fig. 4D) . By contrast, 293 cells co-transfected with the HRE-luciferase and with catalase demonstrated an attenuated expression in response to a similar regimen of H 2 O 2 administration (Fig. 4D) . To determine whether H 2 O 2 acts upstream or downstream of mitochondria, HRE-luciferase expression was examined in 0 -293 cells exposed to a similar regimen of H 2 O 2 (40 M). These 0 -293 cells increased HRE-luciferase expression, indicating that peroxide must act downstream from the mitochondria (Fig. 4D) .
Kinase and Phosphatases Are Activated Downstream from the H 2 O 2 Step-Protein phosphorylation participates in the signaling cascade mediating the accumulation of HIF-1␣ as well as in the transactivation by the HIF-1 complex in response to hypoxia (35) (36) (37) (38) . The phosphatase inhibitor calyculin A (5 nM) abolished HIF-1␣ stabilization in response to hypoxia, CoCl 2 , or DFO in Hep3B cells (Fig. 5A) . Wortmannin (0.1-1.0 M), an inhibitor of PI-3 kinase, attenuated HIF-1␣ accumulation in response to hypoxia, CoCl 2 , or DFO (Fig. 5B) . Wortmannin (500 nM) also attenuated the expression of HRE-luciferase in 293 cells (Fig. 5C ). In the presence of calyculin A or wortmannin, the proteasome inhibitor N-carbobenzoxyl-L-leucinyl-L-leucinyl-L-norvalinal (10 M) was still able to stabilize HIF-1␣ (Fig. 5D ). These observations reveal the following: (a) the inhibited stabilization of HIF-1␣ in the presence of these compounds did not reflect a nonspecific toxic effect, and (b) phosphatases and PI-3 kinases must act upstream of the proteolytic degradation machinery. (Fig. 5E) . Thus, phosphatases and PI-3 kinases are required for the stabilization of HIF-1␣ and act at steps downstream of ROS. To determine whether the inhibition of the HIF-1␣ protein response to hypoxia, CoCl 2 , or DFO by wortmannin was specific to that compound, additional studies were carried out using the PI-3 kinase inhibitor LY 294002. At a concentration of 20 M, this compound also inhibited the stabilization of HIF-1␣ in response to hypoxia, CoCl 2 , or DFO (Fig. 5F ). These results support the conclusion that PI-3 kinase participates in the signaling regulating HIF-1␣ stabilization by acting downstream from the activation by hypoxia, CoCl 2 , and DFO.
Complex III Is the O 2 Sensor for Stabilization of HIF-1␣ during Hypoxia-We previously found that cytochrome c oxidase undergoes a decrease in V max during hypoxia (39) . Cytochrome oxidase in rat hepatocytes requires 90 -120 min under hypoxia to effect this change (40) . Such a decrease could augment the reduction state at more proximal locations in the electron transport chain, conceivably explaining the increase in superoxide generation during hypoxia (41) . To evaluate the temporal relationship between the changes in cytochrome oxidase V max and the stabilization of HIF-1␣, isolated rat hepatocytes were studied under hypoxia. Surprisingly, HIF-1␣ protein stabilization was detected within 30 min at 1.5% O 2 (Fig.  6A ). Rotenone and PDTC abolished this response, whereas antimycin A maintained the hypoxia-induced accumulation of HIF-1␣ (Fig. 6A) . These results are incompatible with the hypothesis that changes in cytochrome c oxidase V max function as the O 2 sensor mediating stabilization of HIF-1␣ during hypoxia. Rather, the data suggest that Complex III exhibits intrinsic sensitivity to [O 2 ], allowing it to serve as an O 2 sensor by increasing its generation of superoxide at low O 2 levels.
ROS generation at Complex III increases when antimycin A inhibits electron flux at its downstream end while succinate is used to supply electrons into it (32, 33) . However, the effects of low [O 2 ] on this process have not been explored. Hence, we assessed the influence of [O 2 ] on ROS generation by Complex III during graded hypoxia by incubating isolated rat liver mitochondria for 30 min with succinate (5 mM, an electron source) in the presence of rotenone (1 g/ml, to block electron transport to/from Complex I) and antimycin A (1 g/ml, to fully reduce Complex III). DCFH (10 M) was used to assess ROS generation at [O 2 ] ranging from 1 to 5%. Under these conditions, graded increases in DCFH oxidation were seen at decreasing O 2 tensions, which were inhibited by further addition of myxothiazol (100 ng/ml) (Fig. 6B) . Myxothiazol inhibits Complex III upstream of the site of ROS generation, thereby confirming the role of Complex III in this response (Fig. 6B) .
ROS production by Complex I has also been reported (33) . To determine if [O 2 ]-dependent of ROS production by Complex I also occurs, mitochondria were incubated under 1% O 2 for 30 min with DCFH, using malate (5 mM) and glutamate (5 mM) to supply electrons to Complex I and rotenone (1 g/ml) to block electron transfer to Complex III. DCFH oxidation by Complex I did not increase during hypoxia (data not shown), indicating that the [O 2 ]-dependent increase in ROS generation during hypoxia is restricted to Complex III.
Many elements of the mitochondrial electron transport system are highly conserved through evolution, including Complex III. The Gram-negative bacterium P. denitrificans contains a respiratory chain in the cell membrane that is similar to eukaryotic mitochondria (42) . To determine whether P. denitrificans demonstrate graded increases in ROS generation during hypoxia, bacterial suspensions were incubated with DCFH under different O 2 levels. Graded increases in DCFH oxidation were observed at decreasing O 2 concentrations (Fig. 6D) . Myxothiazol and rotenone attenuated the increases in DCFH oxidation during 1% O 2 . Antimycin A increased the increase in DCFH oxidation during hypoxia (data not shown). Thus, isolated mitochondria and P. denitrificans display an increase in ROS generation at Complex III in response to hypoxia. Interestingly, the aerobic respiratory chain of Escherichia coli does not contain an analogue to the eukaryotic Complex III (43) . Additional studies were therefore carried out using suspensions of E. coli, to determine whether an organism that lacks a semiquinone step in its respiratory chain would fail to generate ROS during hypoxia. During 1% O 2 incubation, E. coli demonstrated consistent decreases in oxidation of DCFH, compared with control experiments incubated under 21% O 2 (data not shown). These findings provide further support for the conclusion that electrons released from the ubisemiquinone site of Complex III are required for the generation of ROS during hypoxia. DISCUSSION ROS have been proposed to participate in the signal transduction process mediating the stabilization of the transcription factor HIF-1␣ during hypoxia. However, controversy exists regarding whether ROS levels increase or decrease under hypoxia. The present study extends our previous work by demonstrating that HIF-1␣ stabilization by hypoxia or CoCl 2 requires an increase in ROS. Hypoxia and CoCl 2 both elicited an increase in DCF fluorescence, revealing that oxidation of the probe increases prior to the stabilization of HIF-1␣. The antioxidant PDTC abolished the stabilization of HIF-1␣ and oxidation of DCFH in response to hypoxia or CoCl 2 , further suggesting the involvement of ROS. Human 293 cells overexpressing catalase showed an attenuated HRE-luciferase expression response to hypoxia or CoCl 2 , demonstrating the requirement for H 2 O 2 in a second cell line. Finally, administration of H 2 O 2 caused HIF-1␣ stabilization and expression of HRE-luciferase under normoxic conditions in both cell types. Collectively, these findings support the conclusion that ROS are both required and sufficient to activate the signaling system resulting in the stabilization of HIF-1␣. Our findings are consistent with recent reports demonstrating hypoxia-induced increases in ROS generation in mesenteric vessels in vivo (44) and PC12 cells (45) .
Previous studies using exogenous administration of H 2 O 2 (0.1-1 mM) did not detect stabilization of HIF-1 under normoxia. In fact, H 2 O 2 bolus treatment (1 mM) abolished HIF-1-mediated gene transcription during subsequent hypoxia (1% O 2 for 8 h) (19) . Our H 2 O 2 measurements revealed that a bolus of peroxide is rapidly degraded by cells even in serum-free medium, suggesting that administration of repeated boluses might be required to sustain active signaling. Indeed, Hep3B cells responded to H 2 O 2 boluses (every 15 min for 2 h) by demonstrating accumulation of HIF-1␣, whereas 293 cells given H 2 O 2 (40 M every 15 min for 10 h) induced the expression of HRE-luciferase. These observations indicate that low levels of an oxidizing stimulus are sufficient to stabilize HIF-1␣.
The iron chelator DFO also induces HIF-1␣ stabilization and HIF-1-dependent gene activation, but it appears to act at a more downstream site in the signaling cascade. Stabilization of HIF-1␣ by DFO did not appear to involve ROS, as DFO neither increased nor decreased DCF fluorescence during normoxia. The response to DFO was not abolished by either PDTC or catalase, both of which enhanced the scavenging of H 2 O 2 . The flavin inhibitor DPI and the Complex I inhibitor rotenone also failed to abolish HIF-1␣ stabilization during DFO, and 0 Hep3B cells were still able to respond to DFO. However, wortmannin and calyculin A both abolished the HIF-1␣ stabilization during DFO. These findings indicate that DFO does not require mitochondrial electron transport or ROS and appears to be acting at a site downstream from the oxidant-mediated step but upstream from the ubiquitin-proteasome degradation step.
What is the source of ROS that trigger stabilization of HIF-1␣ during hypoxia? Mitochondrial Complex III can generate superoxide anions during normoxia (32, 33) (Fig. 7) . Our data reveal that hypoxia increases the generation of ROS at Complex III to an extent sufficient to stabilize HIF-1␣ protein.
In support of this, respiration-incompetent 0 cells failed to stabilize HIF-1␣, were unable to express HRE-luciferase, and failed to increase oxidation of DCFH during hypoxia. However, 0 cells were able to respond to CoCl 2 and to DFO, indicating that they retained the ability to respond. Moreover, 0 293 cells responded to exogenous H 2 O 2 by inducing expression of HREluciferase. Collectively, these data indicate that an active electron transport chain is required for hypoxic stabilization of HIF-1␣ and that ROS generated during hypoxia are sufficient to effect this stabilization. The Complex I inhibitor rotenone diminished ROS generation by prohibiting the supply of electrons into Complex III. This compound abolished the increase in DCFH oxidation during hypoxia and prevented the increase in HIF-1␣. Rotenone and antimycin A both inhibit electron transport and oxidative phosphorylation, but only the former compound abolished the increases in DCFH oxidation and HIF-1␣ protein during hypoxia. By inhibiting electron transport at the downstream end of Complex III, antimycin A augments superoxide generation, yet we were consistently unable to detect HIF-1␣ stabilization using that compound during normoxia. Because antimycin A caused only a modest increase in DCFH oxidation compared with hypoxia (21), we hypothesized that the failure of antimycin A to stabilize HIF-1␣ could be attributed to the smaller ROS signal. signaling in a cell reflects a balance between the rate of oxidant generation and the efficacy of antioxidant systems. In Hep3B cells depleted of glutathione stores, the ability to metabolize H 2 O 2 would be compromised, which should amplify the effects of a smaller oxidant source. Indeed, HIF-1␣ protein was stabilized in response to antimycin A during normoxia, whereas rotenone, DPI, and PDTC blocked that response in glutathionedepleted Hep3B cells. These observations provide further support for the conclusion that mitochondrial ROS generation at Complex III is required and sufficient for the stabilization of HIF-1␣ during hypoxia.
How do ROS generated in mitochondria escape to the cytosol? Superoxide generated in the mitochondrial matrix can be dismutated to H 2 O 2 by Mn-superoxide dismutase. The H 2 O 2 so produced could diffuse into the cytosol or could be degraded by the mitochondrial antioxidant system. Superoxide generated at Complex III could alternatively enter the cytosol via anion channels in the mitochondrial membranes (29) . Our data show that anion channel inhibition by DIDS abolished the DCFH oxidation observed during hypoxia or with antimycin A during normoxia. By suppressing the egress of mitochondrial superoxide, anion channel inhibition should attenuate the cytosolic oxidant signals that are required for HIF-1␣ stabilization in hypoxia but have no effect on the response to CoCl 2 or to DFO because these responses do not require mitochondria. Indeed, the data show that HIF-1␣ accumulation was abolished by DIDS during hypoxia in Hep3B cells and during antimycin A treatment in glutathione-depleted cells studied during normoxia. However, DIDS did not block the response to CoCl 2 or to DFO. These observations further support the conclusion that an oxidizing stimulus localized to the cytosol is required for the stabilization of HIF-1␣.
Stabilization of HIF-1␣ protein by CoCl 2 or DFO does not require a functional mitochondrial electron transport system, as both were able to stabilize HIF-1␣ protein and induce expression of HRE-luciferase in 0 cells. However, CoCl 2 , unlike DFO, increased the oxidation of DCFH dye, and the CoCl 2 -induced expression HRE-luciferase was attenuated in 0 cells overexpressing catalase. Stabilization of HIF-1␣ by CoCl 2 was not inhibited by DPI, suggesting that cobalt stimulates ROS generation by a non-enzymatic, non-mitochondrial mechanism. The observation that DFO does not require ROS or mitochondria led us to examine whether phosphorylation might serve as a common signaling event linking hypoxia, CoCl 2 , and DFOinduced stabilization of HIF-1␣. Insulin and insulin-like growth factors have been shown to stabilize HIF-1␣ protein and HIF-1-dependent gene expression during normoxia (46) . Two major signaling components in the insulin-activated pathway are phosphatases and PI-3 kinase (47, 48) . Our data indicates that both PI-3 kinases and phosphatases are required for the HIF-1␣ stabilization effected by hypoxia, CoCl 2 , and by DFO. We conclude that PI-3 kinases and phosphatases must be acting upstream of the ubiquitin/proteasome degradation step in the O 2 -sensing pathway, because H 2 O 2 -induced HIF-1␣ stabilization was abolished by wortmannin as well as by calyculin A. Protease and PI-3 kinase inhibitors are toxic to cells at higher concentrations, and toxicity could conceivably inhibit HIF-1␣ stabilization nonspecifically. However, accumulation of HIF-1␣ still occurred during normoxia in response to the proteasome inhibitor N-carbobenzoxyl-L-leucinyl-L-leucinyl-L-norvalinal in the presence of wortmannin or calyculin A, indicating that the cells retained the ability to respond in the presence of these inhibitors. To confirm further that wortmannin was not inhibiting HIF-1␣ stabilization by a nonspecific mechanism, the PI-3 kinase inhibitor LY 294002 was also tested. Like wortmannin, this compound inhibited the response to hypoxia, CoCl 2 , and DFO when used at a concentration of 20 M, thereby supporting the conclusion that PI-3 kinase participates in the signaling pathway required for HIF-1␣ stabilization.
Does cytochrome oxidase act as the O 2 sensor during hypoxia? We previously demonstrated that hypoxia causes a decrease in cytochrome c oxidase V max , which led us to hypothesize this as a mechanism affecting the redox state of cytochromes at more proximal locations. We then postulated that such redox changes might explain the stimulation of superoxide production at low [O 2 ]. In support of this, we noted a similar temporal relationship between the changes in cytochrome c oxidase V max and the ROS generation in cardiomyocytes (41) . However, our current observations appear to be at odds with that hypothesis. Cytochrome c oxidase in rat hepatocytes required 90 -120 min under hypoxia to undergo a decrease in V max (40) , yet these cells displayed HIF-1␣ protein accumulation within 30 min in the present study. Based on the discrepancy between the duration of hypoxia required to effect a change in V max and the duration required to stabilize HIF-1␣, it is unlikely that cytochrome c oxidase could serve as the primary O 2 sensor in hypoxia. Rather, it appears that Complex III must possess inherent sensitivity to [O 2 ], allowing it to adjust its generation of ROS inversely with the O 2 tension. Indeed, our previous observation that ROS generation increased at lower [O 2 ] in Hep3B cells treated with antimycin A (21) is consistent with this conclusion, because electron transport inhibition by antimycin A would fully reduce Complex III, rendering its redox state insensitive to the redox state of cytochrome c oxidase. In the present study, increased oxidant generation by Complex III under hypoxia was confirmed in isolated mitochondria. When electrons were supplied exclusively to Complex III, ROS generation increased during hypoxia confirming the results in intact cells. By contrast, ROS generation tended to decrease during hypoxia when electrons were supplied to only to Complex I, demonstrating the specificity of this response for Complex III. We therefore conclude that Complex III functions as the O 2 sensor during hypoxia by regulating ROS generation inversely with [O 2 ].
In a broader context, it is interesting to note that mitochondria are ubiquitous in eukaryotic cells and could provide a mechanism of O 2 sensing in other physiological responses. Our observation of an increased DCFH oxidation by P. denitrificans, a bacterium that demonstrates important similarities to eukaryotic mitochondria, supports this notion by showing that [O 2 ]-dependent ROS generation by Complex III is not unique to higher organisms. By contrast, E. coli oxidation of DCFH decreased at low O 2 levels, indicating that not all organisms generate an increased oxidant signal under hypoxia. The failure to increase ROS generation by E. coli may relate to its lack of a bc 1 complex, allowing electron transfer to occur without the formation of a ubisemiquinone intermediate (43) . This further supports the conclusion that univalent electron transfer from a semiquinone to O 2 acts as the source of superoxide in cells that contain a functioning bc 1 complex. Future studies will need to address the possibility that mitochondria function as a O 2 sensors and ROS as signaling molecules in other systems.
